1. Introduction {#sec0001}
===============

Gray matter (GM) damage in Multiple Sclerosis (MS), related to both cortical lesion accrual and normal-appearing gray matter microstructural changes ([@bib0024]), occurs largely independent of white matter (WM) lesions ([@bib0016]; [@bib0036]), and shows a significant correlation with clinical disability ([@bib0024]). GM involvement in MS has been extensively studied using MRI, which allows to study both macro- (e.g., GM atrophy) and micro-structural (e.g., changes in water diffusion, macromolecule interactions and relaxometric properties) GM alterations.

In particular, studies of regional atrophy have shown that GM loss in relapsing-remitting multiple sclerosis (RR-MS) preferentially affects the deep gray matter, pre/postcentral regions and the cingulate, GM volume loss in left rolandic cortex significantly correlating with motor disability ([@bib0037]). In addition, evidence points towards the preferential atrophy of specific brain structures in cognitively impaired patients ([@bib0035]; [@bib0051]; [@bib0053]; [@bib0061]), with several neuropsychological test scores correlating with relevant structures ([@bib0001]; [@bib0014]; [@bib0015]; [@bib0023]; [@bib0027]; [@bib0049]; [@bib0066]; [@bib0071]; [@bib0077]).

In addition to regional atrophy, also GM microstructural alterations, as assessed using Diffusion tensor Imaging (DTI) ([@bib0039]), Magnetization Transfer Ratio (MTR) ([@bib0033]; [@bib0059]), and R2\* relaxation rate ([@bib0041],[@bib0040]; [@bib0073]), have shown preferential correlations with cognitive scores in cortical regions relevant to the tested cognitive domains. However, it is not clear whether and to what extent these correlations are independent from macroscopic tissue damage (i.e., whether they are driven by GM atrophy).

Unlike cognitive measures, physical disability scores show a less straightforward pattern of correlations with microstructural GM damage, since voxel-based analyses have so far provided conflicting results, while global GM microstructural integrity measures correlate in general well with physical disability.

In particular, most studies have shown correlation of GM MTR parameters, averaged over the whole GM, with physical disability in RR-MS ([@bib0019]; [@bib0026]), Clinically Isolated Syndromes suggestive of MS ([@bib0018]), Secondary ([@bib0030]) and Primary Progressive ([@bib0021]; [@bib0057]; [@bib0062]) MS patients, as well as in mixed patient groups ([@bib0020]; [@bib0064], [@bib0065]; [@bib0072]; [@bib0075]).

Correlation with physical disability appeared even more significant when GM MTR was combined with R1 in the calculation of macromolecular proton fraction ([@bib0075]), in line with the known correlation between GM relaxation rates and the Expanded Disability Status Scale (EDSS) ([@bib0028]; [@bib0046]).

Similarly, global GM DTI-derived measures have been shown to correlate with EDSS in RR, although not in the early stages ([@bib0029]; [@bib0076]) and in the progressive forms ([@bib0008]) of the disease.

Despite strong evidences for correlations between the overall GM microstructural integrity and physical disability, the available voxel-based analyses, limited to R2\* ([@bib0073]) and diffusivity ([@bib0069]) maps, have failed so far in localizing these correlations in the cortex, while ROI-based analyses of R2\* of the deep GM structures have shown such a correlation in most ([@bib0012]; [@bib0056]; [@bib0063]; [@bib0073]) but not all ([@bib0034]) cases.

Aim of this retrospective study was to assess the role of regional microstructural GM changes, as measured by a voxel-based analysis of R1 and R2 relaxation rate maps, in determining physical disability and cognitive impairment in RR-MS, taking also into account the effect of atrophy by covarying at voxel level for the GM concentration.

2. Material and methods {#sec0002}
=======================

2.1. Patients {#sec0003}
-------------

MRI studies from 241 patients with clinically definite RR-MS according to the McDonald criteria ([@bib0045]) (141 females; mean age 34.6 ± 7.9 y; disease duration 4,9 ± 5.4 y; EDSS 2.4 ± 0.9, range 1--5) were retrospectively analyzed. Patients were selected from the patient population of the MS Center of the University "Federico II" of Naples (Italy) based on the availability of an MRI study suitable for multiparametric relaxometric segmentation, along with an EDSS collected within 1 month from the MRI.

Patients \< 18 year, or with other clinically significant neurological, cerebrovascular or psychiatric disease were excluded, as well as those who had been treated at any time before the MRI with monoclonal antibodies, cytotoxic or immunosuppressive therapies (steroids were deemed acceptable unless administered in the month preceding the MRI scan).

Results of the analysis of the mean R1 and R2 values of GM, WM and WM lesions from these patients have been published separately in a previous work ([@bib0046]).

All studies have been approved by the Institutional Review Board of the "Federico II" University, and all participants gave informed written consent.

2.2. Clinical and neuropsychological assessment {#sec0004}
-----------------------------------------------

The results of a battery of cognitive tests, including Rao\'s Brief Repeatable Battery (BRB) ([@bib0060]) and the Stroop test ([@bib0013]), acquired within one month from the MRI scan, were available in 186 patients.

Briefly, the BRB tests probe verbal learning and long term memory (by the Selective Reminding Test), visuospatial learning (10/36 Spatial Recall Test), information processing speed (Symbol Digit Modalities Test), sustained attention (Paced Auditory Serial Addition Test), and semantic fluency (Word List Generation).

In addition, the ability to inhibit automatic responses was probed by the Stroop test.

For the present work, a Cognitive Index (CI) was calculated as the percentage of impaired cognitive tests ([@bib0046]), compared to available normative data ([@bib0007]; [@bib0013]).

2.3. MRI {#sec0005}
--------

All MRI studies, collected as part of patient participation in clinical trials, observational studies or clinical practice, were acquired on the same 1.5T scanner (Intera, Philips Medical Systems, the Netherlands).

Acquisition protocols (including a single-echo T1-weighted and a double-echo PD/T2-weighted sequence with equal echo time for T1 and PD volumes, as required by the relaxation rate calculation procedure) are reported in [Table 1](#tbl0001){ref-type="table"}. Over time, 3 similar acquisition protocols, differing for slice thickness, Repetition and Echo time have been used, with one protocol (Protocol C in [Table 1](#tbl0001){ref-type="table"}) being also split in two separated protocols, as two different water-fat shifts had been used over time. Additional details on MRI sequences can be found elsewhere ([@bib0046]).Table 1MRI sequences used for multiparametric relaxometric segmentation. DP/T2 sequences in protocol C were acquired with a water/fat shift of either 0.7 (95 patients) or 1.2 (53 patients) pixels. Accordingly, in the analysis four separate acquisition protocols were included as nuisance covariate.Table 1TR/TE (ms)ProtocolnT1-weighted (2 averages)PD-/T2-weightedVoxel size (mm^3^)A (32 slices)60600/152200/15--900.94•0.94•4B (32 slices)86520/151800/15--900.86•0.86•4C (48 slices)148500/102300/10--800.98•0.98•3

For each study, pre-processing steps (summarized in [Fig. 1](#fig0001){ref-type="fig"}) included the following:-Automated rigid body co-registration ([@bib0009]) of the T1w and PD/T2w volumes using the Statistical Parametric Mapping software (SPM, <https://www.fil.ion.ucl.ac.uk/spm>), using normalized mutual information with SPM8 default parameters, to take care of possible between-sequence head movements.-Calculation of the R1, R2 and PD maps, performed according to the general formula of the signal intensity in the transverse steady state for conventional spin-echo images ([@bib0011]), as described in detail elsewhere ([@bib0004], [@bib0002], [@bib0003]).-Segmentation of the co-registered MRI volumes into GM, normal and abnormal WM, and cerebro-spinal fluid, using a fully automated relaxometric method ([@bib0005]; [@bib0054]). Shortly, after a preliminary segmentation performed by assigning the voxels with relaxation rates "typical" for a specific tissue to the corresponding tissue maps, the remaining voxels are assigned to a specific tissue based on a combined probability approach, which takes into account also the relaxation rates of the surrounding voxels.-Notably, this method, which has shown an inter-study standard deviation of 1.1% in repeated normal tissue fractional volumes measurements ([@bib0006]), and an excellent correlation with the manual definition of the MS lesions (*R* = 0.993 at linear regression analysis, 87.3% sensitivity ([@bib0005])), is not affected by lesion-associated bias in the measure of brain tissue volumes in MS ([@bib0055]), so that it does not require lesion masking or filling prior to segmentation.-Spatial normalization ([@bib0010]) of the GM maps to the stereotactic space of the Montreal Neurological Institute (MNI) space using the GM template provided by SPM8.-Application of the resulting spatial normalization matrix to the R1 and R2 maps.-Smoothing (8 mm, full-width at half maximum) of the spatially normalized GM, R1 and R2 maps, to reduce confounding by individual residual anatomical variations and to render the data normally distributed, as required by the Gaussian random field models used for adjusting *p*-values for familywise error ([@bib0025]).Fig. 1Diagram of the pre-processing procedure. From the T1- DP- and T2-weighted images (upper row in the left box), the R1, R2 and PD volumes are calculated. Brain voxels are then segmented based on the corresponding R1, R2 and PD values (lower row in left box). The resulting GM map is spatially normalized to the GM template provided by SPM (lower part of the right box), and resulting spatial normalization parameters are also applied to R1 and R2 volumes (inherently registered to the segmented GM), providing the spatially normalized maps which are entered, after smoothing, in the voxel-based statistical analysis.Fig. 1

2.4. Statistical analysis {#sec0006}
-------------------------

Correlation of R1 and R2 with EDSS and CI were separately assessed voxelwise using the "Biological Parameter Mapping" software package ([@bib0017]), including as nuisance covariates age, sex, MRI protocol, disease duration, and T2-lesion volume, along with the voxelwise GM content provided by each patient\'s smoothed, spatially normalized GM map.

Covarying at voxel level by the GM map allowed assessing the correlations between relaxation rates and clinical scores independent of the local degree of GM atrophy.

As the focus of the work was the correlation between GM relaxation rates and clinical scores, the analysis was restricted by a study-specific GM mask, defined by thresholding at 40% (as defined by visually assessing the anatomic meaningfulness of the resulting mask) the mean of the unsmoothed, spatially normalized GM maps.

Where significant correlations with CI emerged, the analysis was replicated including also the EDSS as additional nuisance covariate, to assess whether these were independent of physical disability.

In addition, to allow for comparison with other studies not focusing specifically on GM and/or not including GM volume correction, these same analyses were replicated using a brain parenchyma mask, obtained thresholding at 40% the average of the unsmoothed normalized brain tissue maps (obtained as the sum of GM, normal-appearing WM and WM lesion masks). Results of these ancillary analyses are reported in the Supplementary data.

For all voxelwise analyses, significance was set to *p* \< 0.05, corrected for family-wise error (FWE) at cluster level, following a cluster-defining threshold of 0.001.

3. Results {#sec0007}
==========

Clusters of significant correlation with EDSS and CI are shown in [Fig. 2](#fig0002){ref-type="fig"} for R1 and in [Fig. 3](#fig0003){ref-type="fig"} for R2, superimposed on the average of the spatially normalized GM maps of the 241 patients.Fig. 2Clusters of significant inverse correlation of R1 with EDSS and CI, superimposed on the average of the spatially normalized GM maps of the 241 patients. Z coordinates are in mm in the MNI space.Fig. 2Fig. 3Clusters of significant inverse correlation of R2 with EDSS and CI, superimposed on the average of the spatially normalized GM maps of the 241 patients. Z coordinates are in mm in the MNI space.Fig. 3

Cluster dimensions are reported in [Table 2](#tbl0002){ref-type="table"} for R1 and [Table 3](#tbl0003){ref-type="table"} for R2, respectively, along with local maxima coordinates and corresponding anatomical labels ([@bib0070]).Table 2Clusters of significant (*p* \< 0.05, FWE-corrected at cluster level) correlation of R1 with Cognitive Index and EDSS, including in the model age, sex, DD and LL as nuisance covariates, along with GM map as voxelwise nuisance covariate. Results of the analysis without and with EDSS included as nuisance covariate are reported.Table 2Cluster\#MNI (mm)ccTXYZStructureEDSS vs. R1 (*n* = 241)16.25.2850−3038R SupraMarginal Gyrus4.6650−1640R Postcentral Gyrus3.6236−1844R Precentral Gyrus22.54.2642−70−26R Cerebellum (Crus 1)31.84.26−54−2042L SupraMarginal Gyrus3.81−40−2042L Postcentral Gyrus41.74.348826R IFG (p. Opercularis)3.68541232R Precentral Gyrus51.14.06−50−7222L Middle Temporal GyrusCI vs. R1 (*n* = 186)12.04.38−242646L Middle Frontal Gyrus21.84.02284−16R Amygdala3.7532−10−24R Hippocampus3.6124−14−24R ParaHippocampal Gyrus31.44.18281446R Middle Frontal Gyrus41.34.066−6216R Calcarine Gyrus3.718−6826R Cuneus51.14.2128−38−6R ParaHippocampal Gyrus3.2636−28−10R Hippocampus60.84.38−6−2248L Middle cingulate & paracingulate gyri70.84.078−6658R PrecuneusCI vs. R1 controlled for EDSS (*n* = 186)11.64.596−6454R Precuneus3.73−6−6662L Precuneus21.54.12−222644L Middle Frontal Gyrus31.24.65−42046L Posterior-Medial Frontal41.04.41−6−2248L Middle cingulate & paracingulate gyri50.83.86281448R Middle Frontal Gyrus3.3924254R Superior Frontal GyrusTable 3Clusters of significant (*p* \< 0.05, FWE-corrected at cluster level) inverse correlation of R2 with Cognitive Index and EDSS, including in the model age, sex, DD and LL. No clusters of significant correlation between R2 and CI were present when EDSS was included in the model.Table 3Cluste \#MNI (mm)StructureccTXYZEDSS vs. R2 (*n* = 241)114.44.9448−1638R Postcentral Gyrus4.4136−1644R Precentral Gyrus4.1638652R Middle Frontal Gyrus3.8152−2024R SupraMarginal Gyrus212.05.25−26−58−18L Cerebellum (VI)4.48−26−68−12L Fusiform Gyrus4.39−50−7222L Middle Temporal Gyrus4.14−36−72−28L Cerebellum (Crus 1)4.04−26−46−16L Fusiform Gyrus3.77−40−64−2L Middle Occipital Gyrus38.45.33−6−7018L Calcarine Gyrus4.9810−6022R Precuneus4.486−7810R Calcarine Gyrus4.3514−7022R Cuneus3.68−14−622L Linual Gyrus3.58−18−7226L Superior Occipital Gyrus3.47−10−7826L Cuneus44.85.27−83416L Anterior cingulate & paracingulate gyri4.81−81232L Middle cingulate & paracingulate gyri3.776442R Anterior cingulate & paracingulate gyri3.4512542R Superior Medial Gyrus53.64.2−40−2042L Postcentral Gyrus4.12−54−2244L Inferior Parietal Lobule62.74.71284426R Middle Frontal Gyrus3.454246−6R IFG (p. Orbitalis)7\
2.64.69−264812L Middle Frontal Gyrus4.2−16624L Superior Frontal Gyrus3.24−1660−4L Superior Orbital Gyrus82.54.438−78−44R Cerebellum (VII)4.168−68−34R Cerebellum (VIII)CI vs. R2 (*n* = 186)11.64.49−242646L Middle Frontal Gyrus20.74.27−50428L Precentral Gyrus30.73.828−38−6R ParaHippocampal Gyrus

When testing correlations between CI and GM relaxation rates, limited clusters of significant inverse correlation with R2 were found bilaterally in the left middle frontal and precentral gyri, and in the parahippocampal GM on the right. Larger clusters of inverse correlation with R1 were found bilaterally in the middle frontal gyri and mesial temporal GM, as well as in the left midcingulate and in the right medial parieto-occipital cortices.

When EDSS was included in the model, no cluster of correlation between CI and R2 remained significant, while significant clusters of inverse correlation could still be demonstrated for R1 in the precuneus, in dorso-lateral prefrontal regions, and in the midcingulate cortex.

When testing correlations between EDSS and GM relaxation rates, extensive clusters of inverse correlation with R2 values were present bilaterally throughout the brain, the most significant being in the right pre- and post-central gyri. For R1, clusters of inverse correlation with EDSS were less diffuse, restricted to bilateral perirolandic and supramarginal cortices, with additional clusters in the Crus I of the right cerebellar hemisphere, and in the posterior part of the left middle temporal gyrus.

The same analysis, when performed using the brain parenchyma mask, confirmed these results for GM, while showing additional clusters of inverse correlation of R1 with the cognitive index in the posterior part of the corpus callosum, and in the iuxtacortical WM of the right posterior insula and temporo-occipital cortex on the right (Supplementary Fig. 1). Similarly, R2 showed additional clusters of inverse correlation with EDSS in the ventral ponto-mesencephalic regions, and with CI in the posterior corpus callosum and iuxtacortical occipital WM on the left (Supplementary Fig. 2).

Results did not change significantly when the same analyses carried out without covarying at voxel level by the GM map (Supplementary Figs. 3 and 4).

4. Discussion {#sec0008}
=============

Current results show, in a large sample of RR-MS, that GM relaxation rates have distinct patterns of correlation with physical disability and cognitive impairment across the cortex, independent of atrophy.

In particular, R2 confirmed a significant inverse correlation with motor function, as probed by EDSS, throughout the cerebral and cerebellar cortices, with perirolandic regions showing the strongest correlation. The relevance of motor cortex involvement for EDSS was confirmed when analyzing R1 maps, which showed a clearly preferential correlation in the rolandic cortices.

On the other hand, CI correlated negatively with R1 in the dorso-lateral prefrontal cortices, mid-cingulate, precuneus, and in the right medial temporal GM, and showed a similar pattern of correlation (although more limited in extension) with R2.

It is presently unclear whether these different patterns are also subtended by different pathological phenomena. Although correlation between R1 and R2 throughout brain tissues is overall quite strong, these two relaxation rates are only partly influenced by the same biological phenomena. In GM in particular, while R1 and R2 are both lowered in cortical lesions, they seem to be differentially affected by pathological changes, with R2 being influenced mainly by demyelination, and R1 by neuronal loss ([@bib0067]; [@bib0068]), and indeed they behave differently in demyelinated cortex, where their ratio is significantly affected ([@bib0047]).

While the definition of the different pathological bases of these two rates was beyond the scope of the present work, we think that their different behaviors in our results (in particular, the more extensive correlations of EDSS with R2 compared to R1, and the opposite pattern when testing their correlations with CI), hint at different pathological substrates.

It is thus tempting to infer that cognitive impairment is related to major changes occurring in specific cortical structures (e.g., neuronal loss), while motor deficits are the consequence of a non-specific damage in the motor cortices (e.g., demyelination, reactive gliosis, and/or inflammatory edema). However, further studies are needed to allow to draw firm conclusions on pathology correlates of these MRI measures.

The present results add to the current limited and apparently conflicting data on regional correlations between microstructural GM alterations and physical disability. In particular, R2 ([@bib0042]), R2\* ([@bib0073]) and DTI studies ([@bib0069]) did not find similar correlations at 3 Tesla, while extensive correlations between R2\* and EDSS, independent of atrophy, have been shown throughout the cortex at 7T ([@bib0043]).

The latter findings are indeed in line with current results, which show an extensive pattern of correlation with EDSS, independent of atrophy, particularly significant in the rolandic cortices. Additional studies on further independent datasets are thus needed to confirm this pattern, and to clarify the strength and clinical significance of these correlations.

Previous ROI-based analyses of R2\* of the deep GM structures have shown a correlation with physical disability in most ([@bib0012]; [@bib0056]; [@bib0063]), but not all cases ([@bib0034]; [@bib0073]).

It is however not surprising that in our study a significant correlations in deep GM did not emerge, given the relative lack of sensitivity of R2 measures to iron accumulation, which is thought to be behind the increases of R2\* that showed correlation with EDSS in some of these studies.

The pattern of correlations with CI partly conflicts with those from previous studies that have probed the correlations between microstructural GM integrity and cognitive status in MS. In particular, [@bib0039] have assessed the correlation of diffusivity parameters with the BRB subtests in RR-MS, showing a correlation of radial diffusivity (a putative measure of myelination) with the Selective Reminding Test in several GM regions. These included the occipital (i.e. angular, calcarine, lingual and fusiform cortex) medial and lateral temporal and thalamic GM, as well as in precuneus and fronto-orbital cortex, and with the Symbol Digit Modalities Test in the left occipital cortex, cerebellum and anterior insula. Reasons for this partial discrepancy may be due to differences in tissue properties probed by relaxation rates and DTI, and to the different analysis strategy, which in that case did not include correction for atrophy. This critical difference, coupled to the larger dataset used for the present study, may explain the different patterns of correlation.

Similarly, in Clinically Isolated Syndromes suggestive of MS, sustained attention scores have been shown to correlate with MTR in right motor cortex and left supramarginal cortex ([@bib0058]), although again this was obtained in a small number of subjects, without correcting for GM atrophy.

Also, a preliminary study of regional correlates of cognitive and physical disability in RR-MS, carried out by voxel-wise analysis of T2 maps ([@bib0042]) has shown the correlation to be essentially limited to WM and subcortical structures, without significant cortical involvement, for cognitive test scores. While differences in the methods of cognitive assessment may here explain differences in results for CI, the lack of correlations in that case may be partly due to the limited number of subjects, coupled with a significant heterogeneity of scanner/protocol combinations (50 subjects studied using 6 different scanner/protocol combinations).

On the other hand, consistent with our results, other studies have shown direct correlation, independent of atrophy, of R2\* with cognitive status in MS patients with mixed disease courses, in cortical regions including parahippocampus, precuneus and prefrontal GM ([@bib0041]; [@bib0073]).

Along this line, correlations with CI of GM relaxation rates in precuneus, medial frontal and medial temporal cortices seem to point to the involvement of the main hubs of the limbic circuits, known to play a role in cognitive impairment of MS patients, as shown by ROI analyses of volumetric, relaxometric and DTI data ([@bib0032], [@bib0031]; [@bib0074]).

Some limitations of our work should be considered when interpreting the present results:

The use of conventional spin-echo images for calculating the relaxation rate maps, while allowing to collect retrospectively a large data set, have imposed a limited axial resolution, resulting in substantial partial volume effects. Studies using recently introduced isotropic 3 D-sequences suitable for relaxometric analysis ([@bib0022]; [@bib0044]; [@bib0050]), are thus needed to confirm these results.

As this was a retrospective study, data from healthy controls were not available, so that no inferences can be done on the normality of the relaxation rates in these patients. However, several previous studies have shown alterations of GM relaxation rates in MS ([@bib0048]), including a recent one in which the same relaxometric segmentation method as in the present work was used ([@bib0052]). In that work R1 and R2 relaxation rates averaged over the whole GM, estimated as per MRI protocol A of the present work, were assessed in a group of RR-MS patients and a small group of healthy controls. Results showed that the mean GM R2 differences between the two groups were highly significant, while R1 differences did not reach significance, in line with the overall more limited correlations showed by R1 with the clinical scores in our data. Further studies are thus needed to clarify the spatial relationship between the present results and the alterations of GM relaxation rates previously documented in MS.

In the present study. R2 maps have been calculated by monoexponential fitting of data from two echo times, close respectively to the T2 of myelin (\~20 ms) and free water (\~80 ms) ([@bib0038]). Accordingly, the resulting R2 values can be affected by changes in tissue composition in terms of the relative prevalence of these two water components, and/or by alterations of their relaxation rates. Studies using multi-echo sequences allowing multiexponential fitting, and correlation with other measures of myelin integrity (e.g. by DTI), are expected to allow to separate the contributions from these two compartments.

For the present study, GM voxels were identified by a relaxometric segmentation method (in which the probability of voxels to be classified as GM depends chiefly on its relaxation rates, which must be typical of that tissue). This introduces a possible bias, as where severe relaxation rate changes are introduced by pathology, missegmentation of GM can occur, thus reducing our capacity to detect possible correlations with clinical scores through two mechanisms:1)apparent local atrophy due to GM missegmentation results in overcorrection when covarying for local GM volume, as was done here using the biological parametric mapping approach;2)the possible presence of regions where GM pathology (and thus relaxation rate changes) is consistently more pronounced, which may result in a locally more restrictive study-specific GM mask, thus excluding those voxels from the analysis.

However, in the ancillary analyses GM results were confirmed when using a brain parenchyma mask, which included also normal-appearing and abnormal WM, and both with and without correction for GM volume.

Accordingly, we think that the main findings of the work are not significantly affected by this mechanism. Further studies, using independent segmentation and relaxation rate calculation methods, are however warranted to fully rule out this potential confounding factor.

5. Conclusion {#sec0009}
=============

We have shown in a large group of RR-MS patients significant regional correlations between R1 and R2 relaxation rates and both cognitive and physical impairment, independent of disease duration, T2-lesion load, and GM atrophy.

The results suggest an extensive correlation in the cortex between microstructural changes and physical disability, with a preferential role of the sensorimotor cortices, where neuronal loss may play a specific role. On the other hand, neuronal loss in the limbic system and dorsolateral prefrontal cortices appear more strictly related to the cognitive symptoms.

Further studies are needed, possibly coupling other measures of microstructural integrity (e.g. MTR and DTI-derived) to relaxation rates, to confirm these findings and to clarify the pathophysiological meaning of these correlations.
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